PND29 THE COST OF ACHIEVING NEDA WHILE USING TWO ALTERNATIVE FORMULATIONS OF INTERFERON BETA-1A FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN PORTUGAL: LET'S LOOK AT EVIDENCE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1799
https://www.valueinhealthjournal.com/article/S1098-3015(19)34177-4/fulltext
Title :
PND29 THE COST OF ACHIEVING NEDA WHILE USING TWO ALTERNATIVE FORMULATIONS OF INTERFERON BETA-1A FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN PORTUGAL: LET'S LOOK AT EVIDENCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34177-4&doi=10.1016/j.jval.2019.09.1799
First page :
Section Title :
Open access? :
No
Section Order :
11561